The FDA has, for a third time, declined to approve reproxalap for the treatment of dry eye disease, according to a press ...

Successful explantation of a corneal microlens for presbyopia and implantation of a trifocal IOL in a patient who developed ...

NIH Director Jay Bhattacharya, MD, PhD, was selected in February to also serve as acting director of the CDC, continuing the ...

New long-acting muscarinic antagonist-long-acting beta agonist users had a decreased risk for a first moderate/severe COPD ...

Adults with moderate to severe plaque psoriasis saw the greatest mean quality-of-life gains with biologic therapy whereas home phototherapy offered lower costs for patients and payers, according to a ...

Patients admitted to hospitals during periods of inadequate nurse staffing relative to typical levels experience ...

The FDA approved icotrokinra for adults and adolescents aged 12 years and older with moderate to severe plaque psoriasis, ...

The reality of practicing medicine in 2026 is that potential liability exists in every specialty — and that, periodically, ...

The FDA has granted fast track designation to the anti-FcRn agent nipocalimab for the treatment of adults with systemic lupus ...

Between 2012 and 2023, there was a trend in total knee arthroplasty toward cementless fixation and an unresurfaced patellae, according to results presented here.“It appears that we are at a tipping ...

Decreases in daytime activity among adults with MS, indicated via accelerometers worn on their wrists, indicated later ...

Chronic kidney disease affects millions of individuals worldwide and is frequently accompanied by profound declines in physical function, muscle mass and overall quality of life. Fatigue, reduced ...